Steroid Dose and Duration, Immortal Time Bias, and Survival After High-grade Immune-Related Adverse Events

被引：4
|
作者：
Reid, Pankti [1 ]
Sparks, Jeffrey A. [2 ]
Bass, Anne R. [3 ,4 ]
机构：
[1] Univ Chicago, Med Ctr, Div Rheumatol, Chicago, IL USA
[2] Brigham & Womens Hosp, Div Rheumatol Inflammat & Immun, Boston, MA USA
[3] Hosp Special Surg, Div Rheumatol, Weill Cornell Med, New York, NY USA
[4] Hosp Special Surg, Weill Cornell Med, 535 E 70th St, New York, NY 10021 USA
来源：
JAMA ONCOLOGY | 2023年 / 9卷 / 05期
关键词：
D O I：
10.1001/jamaoncol.2023.0100
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：723 / 724
页数：2
相关论文
共 50 条
  • [41] Clinical characteristics of gastrointestinal immune-related adverse events of immune checkpoint inhibitors and their association with survival
    Yamada, Kentaro
    Sawada, Tsunaki
    Nakamura, Masanao
    Yamamura, Takeshi
    Maeda, Keiko
    Ishikawa, Eri
    Iida, Tadashi
    Mizutani, Yasuyuki
    Kakushima, Naomi
    Ishikawa, Takuya
    Furukawa, Kazuhiro
    Ohno, Eizaburo
    Honda, Takashi
    Kawashima, Hiroki
    Ishigami, Masatoshi
    Furune, Satoshi
    Hase, Tetsunari
    Yokota, Kenji
    Maeda, Osamu
    Hashimoto, Naozumi
    Akiyama, Masashi
    Ando, Yuichi
    Fujishiro, Mitsuhiro
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (41) : 7190 - 7206
  • [42] Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer
    Dolladille, Charles
    Ederhy, Stephane
    Sassier, Marion
    Cautela, Jennifer
    Thuny, Franck
    Cohen, Ariel A.
    Fedrizzi, Sophie
    Chretien, Basile
    Da-Silva, Angelique
    Plane, Anne-Flore
    Legallois, Damien
    Milliez, Paul U.
    Lelong-Boulouard, Veronique
    Alexandre, Joachim
    JAMA ONCOLOGY, 2020, 6 (06) : 865 - 871
  • [43] Multidisciplinary team management for high grade immune-related adverse events (irAEs): A single center experience.
    Singh, Prabhsimranjot
    Abu-Shawer, Osama
    Brito, Amanda
    Yenulevich, Eric
    Grover, Shilpa
    Abdulnour, Raja-Elie E.
    LeBoeuf, Nicole R.
    Ott, Patrick Alexander
    Hodi, F. Stephen
    Jacobson, Joseph O.
    Rahma, Osama E.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [44] Efficacy and safety of Infliximab for steroid-resistant immune-related adverse events: A retrospective study
    Kadokawa, Yukio
    Takagi, Mari
    Yoshida, Tomoe
    Tatsumi, Akitoshi
    Fujita, Keiko
    Inoue, Takako
    Ohe, Shuichi
    Nakai, Yasutomo
    Yamamoto, Sachiko
    Otsuka, Tomoyuki
    Ishihara, Ryu
    Isei, Taiki
    Kumagai, Toru
    Nishimura, Kazuo
    Imamura, Fumio
    MOLECULAR AND CLINICAL ONCOLOGY, 2021, 14 (04) : 1 - 12
  • [45] Immune-related Adverse Events after Immune Checkpoint Blockade-based Therapy Are Associated with Improved Survival in Advanced Sarcomas
    Rosenbaum, Evan
    Seier, Kenneth
    Bradic, Martina
    Kelly, Ciara
    Movva, Sujana
    Nacev, Benjamin A.
    Gounder, Mrinal M.
    Keohan, Mary L.
    Avutu, Viswatej
    Chi, Ping
    Thornton, Katherine A.
    Chan, Jason E.
    Dickson, Mark A.
    Donoghue, Mark T. A.
    Tap, William D.
    Qin, Li-Xuan
    D'Angelo, Sandra P.
    CANCER RESEARCH COMMUNICATIONS, 2023, 3 (10): : 2118 - 2125
  • [46] Long-term immune-related adverse events after discontinuation of immunotherapy
    Horisberger, Karoline
    Portenkirchner, Carmen
    Rickenbacher, Andreas
    Biedermann, Luc
    Gubler, Christoph
    Turina, Matthias
    IMMUNOTHERAPY, 2021, 13 (09) : 735 - 740
  • [47] Oral and cutaneous immune-related adverse events in cancer patients: Prevalence and overall survival
    de Oliveira Filho, Osias Vieira
    Gibbons, Ivana Lameiras
    Medeiros, Yuri de Lima
    de Oliveira, Thiago Bueno
    Treister, Nathaniel Simon
    Alves, Fabio Abreu
    ORAL DISEASES, 2024,
  • [48] Endocrine Immune-Related Adverse Events Are Independent Predictors of Survival in Patients with Lung Cancer
    Panagiotou, Emmanouil
    Ntouraki, Sofia
    Vathiotis, Ioannis A.
    Livanou, Maria Effrosyni
    Trimis, Athanasios
    Evangelou, Georgios
    Charpidou, Andriani
    Syrigos, Konstantinos
    Peppa, Melpomeni
    CANCERS, 2024, 16 (09)
  • [49] Response to immune checkpoint inhibitor (ICI) rechallenge after high-grade immune related adverse events (irAE) in patients (pts) with metastatic melanoma (MM).
    Shah, Payal
    Boland, Patrick
    Pavlick, Anna C.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [50] Corticosteroids and second-line immunosuppressants for immune-related adverse events and melanoma survival
    Verheijden, R. J.
    Janssen, J. C.
    Putker, A. E.
    Veenstra, S. P. G. R.
    Hospers, G. A. P.
    Aarts, M. J. B.
    Hehenkamp, K. W.
    Doornebosch, V. L. E.
    Verhaert, M.
    Van den Berkmortel, F. W. P. J.
    Burgers, F. H.
    Haanen, J. B. A. G.
    Piersma, D.
    Kapiteijn, E.
    Labots, M.
    Boers-Sonderen, M. J.
    Van der Veldt, A. A. M.
    Aspeslagh, S.
    May, A. M.
    Suijkerbuijk, K. P. M.
    ANNALS OF ONCOLOGY, 2023, 34 : S690 - S691
12345